Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record now presents details of the completed pembrolizumab and vorinostat trial, including its eligibility criteria, treatment plan, measured outcomes, results-related publications, and study dates.
    Difference
    59%
    Check dated 2026-11-08T02:13:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2, while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-31T22:22:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence”.
    Difference
    1%
    Check dated 2026-10-24T22:23:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T22:23:50.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T22:19:26.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details. This indicates restricted access to the trial record.
    Difference
    20%
    Check dated 2026-09-19T20:33:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.